Startup Grind New Haven is dedicated to helping to build a community where local founders, business people, and students can support and teach one another. We look to bring in speakers who want to tell the personal and professional story of how they got where they are today. The New Haven chapter is operated by DallingtonAssay, LLC.
Susan served as President and CEO of CURE (now BioCT) from '13 through Oct '17. Today she's a leader of the CURE Commons accelerator programs, an EIR at Yale OCR and a board member and advisor to many bioscience companies. She led Rib-X Pharmaceuticals (now Melinta) as CEO and cofounder for 11 years, raising $160mm in capital and guiding the development of novel antibiotic treatments.View Details